A radiology group has filed a lawsuit in federal court claiming that a portion of the American Recovery and Reinvestment Act under which medical professionals, beginning in 2015, could face penalties for noncompliance with Meaningful Use rules for the implementation of electronic health records--is "irrational" and should be declared unconstitutional.
Consumers increasingly are choosing Medicare Advantage plans with higher quality ratings, U.S. Department of Health & Human Services Secretary Kathleen Sebelius said Thursday in a statement.
The federal government has launched a widespread campaign to ensure consumers that health insurance exchanges are protected from fraud, just a few hours after a Congressional report warned that the navigator program has weaknesses that expose it to potential fraud.
The American College of Physicians, in a letter addressed to federal health officials Thursday, says that the "very aggressive" timeline and "overly ambitious" objectives of Meaningful Use Stage 2 threaten to limit the success of the overall program.
The battle between rival industry groups trying to influence the timing of the U.S. Food and Drug Administration's release of its final guidance on mobile medical applications continues to heat...
National Coordinator for Health Information Technology Farzad Mostashari will resign this fall, U.S. Secretary of Health & Human Services Secretary Kathleen Sebelius announced in a letter sent to staffers Tuesday.
A coalition of 15 patient groups said it wants to see the Food and Drug Administration Safety Innovation Act workgroup take its time in crafting a risk-based framework for health IT regulation, in a letter sent to federal officials this week.
Legislation introduced by Rep. Pat Meehan (R-Pa.) calls for a one-year delay in the launch of the controversial data hub that will connect state health insurance exchanges created under the Affordable Care Act with federal agencies.
The American Hospital Association and the American Medical Association, concerned that Meaningful Use requirements are "overly burdensome," make four recommendations to improve the program for providers in a letter sent to U.S. Department of Health & Human Services Secretary Kathleen Sebelius this week.
By his own admission, Bradley Thompson, an attorney at Washington, D.C.-based law firm Epstein Becker Green, has spent 27 years "attacking" the U.S. Food and Drug Administration. At the...